Livzon Pharmaceutical Group reports share repurchase activities

Livzon Pharmaceutical Group (SZSE:000513) announced its daily share repurchase activities on April 21, 2025. The company repurchased 142,800 A-shares on the Shenzhen Stock Exchange at prices between RMB34.28 and RMB34.44, totaling RMB4,906,986. Additionally, there were multiple uncancelled H-share repurchases from July 2024 to January 2025 at different values. The company confirmed that the repurchases adhered to regulations and that information provided was accurate and unchanged from previous submissions. As of April 18, 2025, Livzon's total issued shares, excluding treasury shares, stood at 604,293,313 A-shares and 307,052,417 H-shares.